Erin Burkhart, GVP, Chief Accounting Officer: Biomarin Pharmaceutical BMRN Sell · Filed 25/03/20

Trade details

Type: Insider sale
Amount: $92,618.4
Shares · price: 1,295 sh · $71.52 a share
Held after: 16,955 sh
Stock: Biomarin Pharmaceutical BMRN
Person: Erin BurkhartGVP, Chief Accounting Officer
Trade date: 25/03/19
Filed: 25/03/20
Days to filing: 1 days

Sold 7.1% of holdings

Share of holding sold: 7.1%

Biomarin Pharmaceutical trades, last 26 weeks

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 25/02/17~25/04/18

Erin Burkhart's recent trades

Erin BurkhartGVP, Chief Accounting Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$105.9K
1,786 sh
$105.9K
Filed 25/05/20
Traded 25/05/20
Erin BurkhartOfficer
Planned sale10b5-1 planBiomarin Pharmaceutical
Planned sale10b5-1 plan
Biomarin Pharmaceutical
BMRN
$105.9K
1,786 sh
$105.9K
Filed 25/05/20
Traded 25/05/20
Erin BurkhartOfficer
Planned sale10b5-1 planBiomarin Pharmaceutical
Planned sale10b5-1 plan
Biomarin Pharmaceutical
BMRN
$92.6K
1,295 sh
$92.6K
Filed 25/03/19
Traded 25/03/19
Erin BurkhartGVP, Chief Accounting Officer
Sell10b5-1 planBiomarin Pharmaceutical
Sell10b5-1 plan
Biomarin Pharmaceutical
BMRN
$91.9K
1,344 sh
$91.9K
Filed 25/02/25
Traded 25/02/24
Erin BurkhartOfficer
Planned sale10b5-1 planBiomarin Pharmaceutical
Planned sale10b5-1 plan
Biomarin Pharmaceutical
BMRN
$91.9K
1,344 sh
$91.9K
Filed 25/02/24
Traded 25/02/24